--- title: "FOXO completes 1-for-3,000 reverse stock split" url: "https://aibio.space/news/foxo-completes-1-3-000-reverse-stock-split/" publisher: "aibio.space (Biotech Investor Relations News)" date: "2026-07-01" section: "Listings" tickers: "OTC:FOXO" source: "https://www.sec.gov/Archives/edgar/data/1812360/000149315226031543/ex99-1.htm" summary: "The reverse split of FOXO's Class A common stock took effect at 4:01 p.m. ET on June 30, 2026. Shares trade on a split-adjusted basis under the temporary s" --- By the aibio.space news desk. Sources - [FOXO TECHNOLOGIES INC. 8-K (2026-07-01)](https://www.sec.gov/Archives/edgar/data/1812360/000149315226031543/ex99-1.htm) - [FOXO TECHNOLOGIES INC. financial data (SEC XBRL)](https://www.sec.gov/Archives/edgar/data/1812360/000149315226016725/) [FOXO](https://aibio.space/companies/foxo-technologies/) 2026-07-01 # FOXO completes 1-for-3,000 reverse stock split Tickers [FOXO](https://aibio.space/companies/foxo-technologies/) The reverse split of FOXO's Class A common stock took effect at 4:01 p.m. ET on June 30, 2026. Shares trade on a split-adjusted basis under the temporary symbol FOXOD until the symbol reverts to FOXO on or about July 20, 2026. ## Key facts - **Company**: FOXO TECHNOLOGIES INC. (OTC: FOXO) - **News type**: Listings - **Primary source**: [FOXO TECHNOLOGIES INC. 8-K (2026-07-01)](https://www.sec.gov/Archives/edgar/data/1812360/000149315226031543/ex99-1.htm) *The stone facade of a federal building. Photo: Carol M Highsmith, CC0, via rawpixel. The picture shows the field, not the companies named.* FOXO Technologies Inc. (OTC: [FOXO](https://aibio.space/companies/foxo-technologies/)) said its previously approved reverse stock split of its Class A common stock became effective at 4:01 p.m. ET on June 30, 2026. The company announced the completion in a release dated July 1, 2026, which it filed with the SEC on Form 8-K. ## Trading and symbol The common stock began trading on a split-adjusted basis on the OTC on July 1, 2026, under the temporary symbol FOXOD. It trades under a new CUSIP number, 351471602. The trading symbol is expected to revert to FOXO on or about July 20, 2026, which the release describes as about 20 business days after the effective time. ## The split The reverse split was approved by written consent in lieu of a meeting, by a shareholder holding a majority of the company's voting control, on May 18, 2026. FOXO filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of Delaware to implement it. Every three thousand (3,000) shares of Class A common stock outstanding at the effective time were combined into one share. The par value remains $0.0001 per share. No fractional shares will be issued. Any fraction that would otherwise result is rounded up to the nearest whole share, and no stockholder will receive cash in lieu of a fraction. Continental Stock Transfer & Trust Company, the company's transfer agent, will act as exchange agent. It will send instructions to holders of physical certificates on exchanging them for split-adjusted shares in book-entry form. Holders in street name will receive instructions from their brokers. ## Why the company gave for the split The release says the split is intended to raise the per share price so the stock can qualify for quotation on the OTCQB, which requires a sustained trading price of $0.01 or higher. It also describes the split as a step toward a possible up-listing to a recognized exchange, if the company meets the initial listing requirements and decides to pursue one. The company says that if a higher share price helps it attract professional investors and institutions, the stock could gain liquidity and a stronger investor base. It also said it may explore financing or strategic transactions that would require issuing additional shares, but that no such plans are pending. A split on this scale means the stock was trading below the $0.01 OTCQB threshold before it, and it does not change what the company is worth: the release itself says it does not change the rights of holders. Higher liquidity and an exchange listing are hopes, and the release gives no commitment to either. The release says the split does not change the terms of the outstanding common stock or the rights of its holders, and that the company does not expect it to affect current or future operations. Outstanding stock options, warrants and equity incentive plans will be adjusted proportionately in accordance with their terms. ## Business and financial position The release describes FOXO as owning four subsidiaries. Rennova Community Health, Inc. owns and operates Scott County Community Hospital, Inc., which does business as Big South Fork Medical Center, a critical access hospital in East Tennessee. Myrtle Recovery Centers, Inc. operates a 30-bed behavioral health facility in East Tennessee. Vector BioSource, Inc. provides biospecimen sourcing to the biotechnology, clinical research and pharmaceutical research industries. FOXO Labs, Inc. is a biotechnology company. The company's annual report for 2025, filed April 15, 2026, shows revenue of $16.4 million, compared with $4.1 million for 2024. The net loss was $12.4 million in both years. Cash from operations was negative $3.9 million in 2025, compared with negative $2.8 million in 2024. ## What comes next The release says the company does not expect the split to affect its business operations, and it contains no operating or financing news. The company lost $12.4 million in 2025 and used $3.9 million of cash in operations, so the split fixes a quotation problem and does not address those losses. The symbol change back to FOXO is expected on or about July 20, 2026. [Report an error](https://aibio.space/reputation/#correction) ## Companies in this story FOXO FOXO TECHNOLOGIES INC. OTC ยท United States Open the starter desk ## More in Listings Listings ### [Propanc Biopharma faces Nasdaq delisting on bid price, plans to appeal](https://aibio.space/news/propanc-biopharma-faces-nasdaq-delisting-bid-price-plans-appeal/) Oct 29, 2026 Listings ### [Reviva asks stockholders to approve reverse split of up to 1-for-100](https://aibio.space/news/reviva-asks-stockholders-approve-reverse-split-up-1-100/) Oct 29, 2026 Listings ### [Nasdaq to delist Glucotrack shares after bid price exception ends](https://aibio.space/news/nasdaq-delist-glucotrack-shares-after-bid-price-exception-ends/) Oct 28, 2026 --- Source page: https://aibio.space/news/foxo-completes-1-3-000-reverse-stock-split/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "FOXO completes 1-for-3,000 reverse stock split", 2026-07-01, https://aibio.space/news/foxo-completes-1-3-000-reverse-stock-split/